Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-IMMUNOME
IMNM Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-03-27
2025-03-28
HIGGINS JACK
Chief Scientific Officer
M - Exercise
Common Stock
5,200
$1.00
5,200
1
$806.6M
2025-03-27
2025-03-28
HIGGINS JACK
Chief Scientific Officer
M - Exercise
Employee Stock option (right to buy)
-5,200
$0.00
1
$806.6M
2025-03-24
2025-03-25
TSAI PHILIP
Chief Technology Officer
P - Purchase
Common Stock
12,300
$8.00
98,400
1
$806.6M
2024-11-22
2024-11-25
SIEGALL CLAY
President and CEO
P - Purchase
Common Stock
33,943
$10.00
339K
1
$806.6M
2024-11-21
2024-11-25
SIEGALL CLAY
President and CEO
P - Purchase
Common Stock
66,057
$10.00
661K
1
$806.6M
2024-11-21
2024-11-25
TSAI PHILIP
Chief Technology Officer
P - Purchase
Common Stock
21,000
$9.00
189K
1
$806.6M
2024-11-21
2024-11-25
LECHLEIDER ROBERT
Chief Medical Officer
P - Purchase
Common Stock
15,805
$9.00
142K
1
$806.6M
2024-09-19
2024-09-20
ROSETT MAX
Chief Financial Officer
M - Exercise
Stock option (right to buy)
-42,000
$0.00
1
$806.6M
2024-09-19
2024-09-20
ROSETT MAX
Chief Financial Officer
M - Exercise
Common Stock
42,000
$1.00
42,000
1
$806.6M
2024-09-19
2024-09-20
ROSETT MAX
Chief Financial Officer
S - Sale
Common Stock
-14,380
$16.00
-230K
1
$806.6M
2024-08-15
2024-08-19
HIGGINS JACK
Chief Scientific Officer
S - Sale
Common Stock
-3,524
$14.00
-49,336
1
$806.6M
2024-08-15
2024-08-19
HIGGINS JACK
Chief Scientific Officer
M - Exercise
Stock option (right to buy)
-19,524
$0.00
1
$806.6M
2024-08-15
2024-08-19
HIGGINS JACK
Chief Scientific Officer
M - Exercise
Common Stock
19,524
$1.00
19,524
1
$806.6M
2024-08-09
2024-08-13
HIGGINS JACK
Chief Scientific Officer
A - Grant
Stock option (right to buy)
190K
$0.00
1
$806.6M
2024-08-09
2024-08-13
HORN KINNEY
CHIEF BUSINESS OFFICER
A - Grant
Stock option (right to buy)
130K
$0.00
1
$806.6M
2024-08-09
2024-08-13
LECHLEIDER ROBERT
Chief Medical Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$806.6M
2024-08-09
2024-08-13
ROSETT MAX
EVP, Operations & CFO
A - Grant
Stock option (right to buy)
190K
$0.00
1
$806.6M
2024-08-09
2024-08-13
SIEGALL CLAY
President and CEO
A - Grant
Stock option (right to buy)
800K
$0.00
1
$806.6M
2024-08-09
2024-08-13
STONEMAN SANDRA
CHIEF LEGAL OFFICER & GC
A - Grant
Stock option (right to buy)
210K
$0.00
1
$806.6M
2024-08-09
2024-08-13
TURNER BRUCE
Chief Strategy Officer
A - Grant
Stock option (right to buy)
110K
$0.00
1
$806.6M
2024-06-17
2024-06-18
TSAI PHILIP
Chief Technology Officer
A - Grant
Stock option (right to buy)
250K
$0.00
1
$806.6M
2024-06-13
2024-06-18
BIENAIME JEAN JACQUES
A - Grant
Stock option (right to buy)
11,333
$0.00
1
$806.6M
2024-05-21
2024-05-21
SIEGALL CLAY
President and CEO
P - Purchase
Common Stock
20,434
$14.00
286K
1
$806.6M
2024-05-20
2024-05-21
SIEGALL CLAY
President and CEO
P - Purchase
Common Stock
79,566
$14.00
1.11M
1
$806.6M
2024-05-16
2024-05-17
ROSETT MAX
EVP, Operations & CFO
A - Grant
Stock option (right to buy)
30,000
$0.00
1
$806.6M
2024-02-20
2024-02-21
HORN KINNEY
CHIEF BUSINESS OFFICER
A - Grant
Stock option (right to buy)
300K
$0.00
1
$806.6M
2024-01-31
2024-01-31
STONEMAN SANDRA
CHIEF LEGAL OFFICER & GC
A - Grant
Stock option (right to buy)
200K
$0.00
1
$806.6M
2024-01-31
2024-01-31
ROSETT MAX
EVP, OPERATIONS & INTERIM CFO
A - Grant
Stock option (right to buy)
175K
$0.00
1
$806.6M
2023-12-13
2023-12-15
ROBERTS PHIL NOLAND
Chief Technology Officer
A - Grant
Stock option (right to buy)
275K
$0.00
1
$806.6M
2023-12-01
2023-12-05
HIGGINS JACK
Chief Scientific Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$806.6M
2023-11-07
2023-11-09
BIENAIME JEAN JACQUES
A - Grant
Stock option (right to buy)
40,696
$0.00
1
$806.6M
2023-10-27
2023-10-31
LECHLEIDER ROBERT
Chief Medical Officer
A - Grant
Stock option (right to buy)
400K
$0.00
1
$806.6M
2023-10-02
2023-10-04
PRENDERGAST FRANKLYN
A - Grant
Stock Option (Right to Buy)
138K
$1.00
138K
1
$806.6M
2023-10-02
2023-10-04
TURNER BRUCE
Chief Strategy Officer
P - Purchase
Common Stock
42,300
$6.00
254K
1
$806.6M
2023-06-08
2023-06-12
GIESING DENNIS
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$806.6M
2023-06-08
2023-06-12
ROBINSON MATTHEW
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
58,000
$0.00
1
$806.6M
2023-06-08
2023-06-12
ROCHE CORLEEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
58,000
$0.00
1
$806.6M
2023-06-08
2023-06-12
SARMA PURNANAND
President and CEO
A - Grant
Stock Option (Right to Buy)
167K
$0.00
1
$806.6M
2023-06-08
2023-06-12
STONEMAN SANDRA
General Counsel and CLO
A - Grant
Stock Option (Right to Buy)
56,000
$0.00
1
$806.6M
2022-06-16
2022-06-21
GIESING DENNIS
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$806.6M
2022-06-16
2022-06-21
ROBINSON MATTHEW
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$806.6M
2022-06-16
2022-06-21
ROCHE CORLEEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$806.6M
2022-06-16
2022-06-21
SARMA PURNANAND
President and CEO
A - Grant
Stock Option (Right to Buy)
121K
$0.00
1
$806.6M
2022-06-16
2022-06-21
STONEMAN SANDRA
General Counsel and CLO
A - Grant
Stock Option (Right to Buy)
43,000
$0.00
1
$806.6M
2021-05-28
2021-06-01
GIESING DENNIS
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
16,609
$0.00
1
$806.6M
2021-05-28
2021-06-01
ROCHE CORLEEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
16,609
$0.00
1
$806.6M
2021-05-28
2021-06-01
SARMA PURNANAND
president and CEO
A - Grant
Stock Option (Right to Buy)
93,354
$0.00
1
$806.6M
2021-05-28
2021-06-01
STONEMAN SANDRA
General Counsel and CLO
A - Grant
Stock Option (Right to Buy)
16,609
$0.00
1
$806.6M
2021-05-25
2021-05-26
SARMA PURNANAND
President and CEO
P - Purchase
Common Stock
10,500
$18.00
189K
1
$806.6M
2021-04-19
2021-04-21
ROCHE CORLEEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$806.6M
2021-03-25
2021-03-29
GIESING DENNIS
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$806.6M
2020-11-03
2020-11-05
STONEMAN SANDRA
Chief Legal Officer & Gen Coun
A - Grant
Employee Stock Option (Right to Buy)
149K
$0.00
1
$806.6M
2020-10-06
2020-10-08
RAPP MICHAEL
C - Conversion
Series A Convertible Preferred Stock
-556K
$0.00
1
$806.6M
2020-10-06
2020-10-08
WIDLITZ MICHAEL
C - Conversion
Series A Convertible Preferred Stock
-51,315
$0.00
1
$806.6M
2020-10-06
2020-10-08
LAMATTINA JOHN
C - Conversion
Series A Convertible Preferred Stock
-46,388
$0.00
1
$806.6M
2020-10-06
2020-10-08
LEFENFELD MICHAEL
C - Conversion
Series A Convertible Preferred Stock
-22,222
$0.00
1
$806.6M
2020-10-06
2020-10-08
MORRIS WISTAR III
C - Conversion
Series A Convertible Preferred Stock
-921K
$0.00
2
$806.6M
2020-10-01
2020-10-05
FITZGERALD RICHARD
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
112K
$0.00
2
$806.6M